Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

John A. Charlson MD

John A. Charlson MD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center


Publications (39)

  • High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. (Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN) Surgery 2020 Oct;168(4):760-767 PMID: 32736869 SCOPUS ID: 2-s2.0-85088789886 08/02/2020    
  • A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas. (Monga V, Skubitz KM, Maliske S, Mott SL, Dietz H, Hirbe AC, Van Tine BA, Oppelt P, Okuno S, Robinson S, O'Connor M, Seetharam M, Attia S, Charlson J, Agulnik M, Milhem M) Cancers (Basel) 2020 Jul 11;12(7) PMID: 32664595 PMCID: PMC7408640 07/16/2020    
  • Adolescents and Young Adults with Cancer Using a Symptom Heuristics App: Provider Perceptions and Actions. (Macpherson CF, Stegenga K, Erickson JM, Linder LA, Newman AR, Elswick RK, Charlson J, Thomas S, Ameringer S) J Adolesc Young Adult Oncol 2020 Oct;9(5):579-585 PMID: 32326804 PMCID: PMC7578178 SCOPUS ID: 2-s2.0-85092749707 04/25/2020    
  • Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. (Thalji SZ, Tsai S, Gamblin TC, Clarke C, Christians K, Charlson J, Ethun CG, Poultsides G, Grignol VP, Roggin KK, Votanopoulos K, Fields RC, Abbott DE, Cardona K, Mogal H, other members of the US Sarcoma Collaborative) J Surg Oncol 2020 Jun;121(7):1140-1147 PMID: 32167587 SCOPUS ID: 2-s2.0-85081732672 03/14/2020    
  • Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity? (Bedi M, Ethun CG, Charlson J, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Cardona K, King DM) Clin Orthop Relat Res 2020 03;478(3):550-559 PMID: 32168066 PMCID: PMC7145071 SCOPUS ID: 2-s2.0-85081980953 03/14/2020    
  • Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. (Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH) J Surg Res 2020 01;245:577-586 PMID: 31494391 SCOPUS ID: 2-s2.0-85071720617 09/09/2019    
  • Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma. (Patel S, von Mehren M, Reed DR, Kaiser P, Charlson J, Ryan CW, Rushing D, Livingston M, Singh A, Seth R, Forscher C, D'Amato G, Chawla SP, McCarthy S, Wang G, Parekh T, Knoblauch R, Hensley ML, Maki RG, Demetri GD) Cancer 2019 08 01;125(15):2610-2620 PMID: 31173362 PMCID: PMC6771856 SCOPUS ID: 2-s2.0-85068993041 06/08/2019       6 Citations
  • The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. (Gannon NP, King DM, Ethun CG, Charlson J, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Votanopoulos K, Krasnick B, Fields RC, Cardona K, Bedi M) J Surg Oncol 2019 Sep;120(3):325-331 PMID: 31172531 SCOPUS ID: 2-s2.0-85070851045 06/07/2019       4 Citations
  • Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1. (Zarnecki KG, Kristianto J, Charlson J, Wilson B, Blank RD, Shaker JL) Osteoporos Int 2019 Aug;30(8):1699-1703 PMID: 31079185 SCOPUS ID: 2-s2.0-85065707987 05/13/2019       1 Citation
  • Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. (Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Weber S, Gamblin TC, Cardona K, Clarke CN) J Surg Res 2019 01;233:154-162 PMID: 30502242 SCOPUS ID: 2-s2.0-85051762456 12/07/2018       3 Citations
  • Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy. (Charlson J) Curr Treat Options Oncol 2018 10 25;19(12):65 PMID: 30361919 SCOPUS ID: 2-s2.0-85055453382 10/27/2018       1 Citation
  • Primary angiosarcoma of the testis with retroperitoneal metastasis. (Piotrowski JT, Schaefer MB, Charlson JA, Iczkowski KA, Johnson SC) Urol Case Rep 2018 Nov;21:116-118 PMID: 30294549 PMCID: PMC6168964 10/09/2018    
  • Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma. (Yu PY, Beal EW, Hughes TM, Suarez-Kelly LP, Shelby RD, Ethun CG, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH) J Surg Res 2018 11;231:248-256 PMID: 30278937 SCOPUS ID: 2-s2.0-85048892540 10/04/2018       2 Citations
  • A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative database. (Johnson AC, Ethun CG, Liu Y, Poultsides G, Howard JH, Bedi M, Charlson J, Tseng J, Roggin KK, Votanopoulos K, Cullinan D, Fields RC, Maithel SK, Cardona K, and other members of the US Sarcoma Collaborative) J Surg Oncol 2018 Dec;118(7):1135-1141 PMID: 30261111 SCOPUS ID: 2-s2.0-85053921013 09/28/2018       5 Citations
  • Postoperative Day 1 Glucose May Be Associated With Wound Complications in Sarcomas Treated With Preoperative Radiation. (Bedi M, King DM, Mendez C, Slawski B, Charlson JA, Hackbarth DA, Neilson JC) Clin Orthop Relat Res 2018 03;476(3):580-586 PMID: 29529645 PMCID: PMC6260049 SCOPUS ID: 2-s2.0-85056549830 03/13/2018    
  • Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy. (Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, Laud PW, Charlson JA) J Cancer Surviv 2018 04;12(2):268-275 PMID: 29243101 SCOPUS ID: 2-s2.0-85038093950 12/16/2017       4 Citations
  • Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D. (Charlson JA, McGinley EL, Nattinger AB, Neuner JM, Pezzin LE) J Natl Compr Canc Netw 2017 12;15(12):1509-1517 PMID: 29223989 SCOPUS ID: 2-s2.0-85038431887 12/11/2017    
  • Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base. (Berger NG, Silva JP, Mogal H, Clarke CN, Bedi M, Charlson J, Christians KK, Tsai S, Gamblin TC) Surgery 2018 02;163(2):318-323 PMID: 28943041 SCOPUS ID: 2-s2.0-85029656379 09/26/2017       15 Citations
  • Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy. (Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM) J Clin Oncol 2016 12 20;34(36):4398-4404 PMID: 27998232 PMCID: PMC5455308 SCOPUS ID: 2-s2.0-85009740911 12/22/2016       16 Citations
  • Preoperative Radiation Therapy Followed by Reexcision May Improve Local Control and Progression-Free Survival in Unplanned Excisions of Soft Tissue Sarcomas of the Extremity and Chest-Wall. (Saeed H, King DM, Johnstone CA, Charlson JA, Hackbarth DA, Neilson JC, Bedi M) Int J Surg Oncol 2016;2016:5963167 PMID: 27803813 PMCID: PMC5075633 SCOPUS ID: 2-s2.0-84993978494 11/03/2016       4 Citations
  • Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors. (Charlson J, Smith EC, Smallwood AJ, Laud PW, Neuner JM) J Natl Compr Canc Netw 2016 07;14(7):875-80 PMID: 27407128 SCOPUS ID: 2-s2.0-84978910683 07/14/2016       3 Citations
  • Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)? (Klooster B, Rajeev R, Chrabaszcz S, Charlson J, Miura J, Bedi M, Gamblin TC, Johnston F, Turaga KK) J Surg Oncol 2016 Jun;113(7):823-7 PMID: 27060344 SCOPUS ID: 2-s2.0-84963686460 04/10/2016       6 Citations
  • Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma. (Kashtan MA, Jayakrishnan TT, Rajeev R, Charlson JC, Johnston F, Clark Gamblin T, Turaga KK) Int J Clin Oncol 2016 Jun;21(3):602-8 PMID: 26646222 SCOPUS ID: 2-s2.0-84949484118 12/10/2015       1 Citation
  • Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. (Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM) Springerplus 2015;4:531 PMID: 26413437 PMCID: PMC4577495 09/29/2015    
  • Biopsies in the Community Lead to Postoperative Complications in Soft Tissue Sarcomas. (Bedi M, King DM, Hackbarth DA, Charlson JA, Baynes K, Neilson JC) Orthopedics 2015 Sep;38(9):e753-9 PMID: 26375531 SCOPUS ID: 2-s2.0-84941278514 09/17/2015       2 Citations
  • Retroperitoneal solitary fibrous tumor: surgery as first line therapy. (Rajeev R, Patel M, Jayakrishnan TT, Johnston FM, Bedi M, Charlson J, Turaga KK) Clin Sarcoma Res 2015;5:19 PMID: 26322223 PMCID: PMC4551387 09/01/2015    
  • Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma. (Miura JT, Charlson J, Gamblin TC, Eastwood D, Banerjee A, Johnston FM, Turaga KK) Eur J Surg Oncol 2015 Oct;41(10):1386-92 PMID: 26251340 SCOPUS ID: 2-s2.0-84943818360 08/08/2015       38 Citations
  • Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result. (Andreason M, Zhang C, Onitilo AA, Engel J, Ledesma WM, Ridolfi K, Kim K, Charlson JC, Wisinski KB, Tevaarwerk AJ) J Community Support Oncol 2015 May;13(5):195-201 PMID: 26029936 PMCID: PMC4511377 06/02/2015    
  • The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees. (Neuner JM, Kamaraju S, Charlson JA, Wozniak EM, Smith EC, Biggers A, Smallwood AJ, Laud PW, Pezzin LE) J Natl Cancer Inst 2015 Aug;107(8) PMID: 25971298 PMCID: PMC4580559 SCOPUS ID: 2-s2.0-84939643031 05/15/2015       28 Citations
  • Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. (Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM) Springerplus 2015;4:54 PMID: 25674506 PMCID: PMC4320689 02/13/2015    
  • Drug induced periarticular thenar erythema with onycholysis related to nano-albumin bound paclitaxel therapy (Dow EN, Piccolo J, Segal EM, Charlson JA) Cancer Treatment Communications 2015;4:161-164 SCOPUS ID: 2-s2.0-84947911220 01/01/2015    
  • Drug induced periarticular thenar erythema with onycholysis related to nano-albumin bound paclitaxel therapy Cancer Treatment Communications 2015;4:161-164 01/01/2015    
  • Medicare Part D low-income subsidy and disparities in breast cancer treatment. (Neuner J, Smith E, Charlson JA, Pezzin L, Laud P) J Clin Oncol 2014 Oct 20;32(30_suppl):2 PMID: 28141273 10/20/2014    
  • The effect of smoking and major vein resection on post-therapy lymphedema in soft tissue sarcomas treated with neoadjuvant radiation and limb-salvage surgery. (Bedi M, King DM, Whitfield R, Hackbarth DA, Neilson JC, Charlson JA, Wang D) Am J Clin Oncol 2015 Apr;38(2):184-8 PMID: 23563214 SCOPUS ID: 2-s2.0-84926408438 04/09/2013       4 Citations
  • Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy. (Bedi M, King DM, Shivakoti M, Wang T, Zambrano EV, Charlson J, Hackbarth D, Neilson J, Whitfield R, Wang D) Radiat Oncol 2013 Mar 14;8:60 PMID: 23497372 PMCID: PMC3621722 SCOPUS ID: 2-s2.0-84874932091 03/19/2013       15 Citations
  • Multimodality management of metastatic patients with soft tissue sarcomas may prolong survival. (Bedi M, King DM, Charlson J, Whitfield R, Hackbarth DA, Zambrano EV, Wang D) Am J Clin Oncol 2014 Jun;37(3):272-7 PMID: 23275272 SCOPUS ID: 2-s2.0-84908046611 01/01/2013       5 Citations
  • A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer. (Yao X, Hosenpud J, Chitambar CR, Charlson J, Cheng YC) J Cancer 2012;3:145-51 PMID: 22481980 PMCID: PMC3319980 04/07/2012    
  • Adamantinoma with plasmacytoid features: expanding the spectrum of a diagnostically challenging entity. (Walters MP, Baynes K, Carrera GF, King DM, Wang D, Charlson J, Zambrano E) Ann Diagn Pathol 2011 Oct;15(5):347-54 PMID: 20952283 SCOPUS ID: 2-s2.0-80052864102 10/19/2010       1 Citation
  • Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. (Fuller CK, Charlson JA, Dankle SK, Russell TJ) J Am Acad Dermatol 2010 Oct;63(4):e83-4 PMID: 20846560 SCOPUS ID: 2-s2.0-77956717395 09/18/2010       29 Citations
  • Last update: 08/22/2020
    jenkins-FCD Prod-482 91ad8a360b6da540234915ea01ff80e38bfdb40a